Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • OREXIGEN THERAPEUTICS INC Analyst Recommendations

  • Analyst Consensus: OREX

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.375 Strong Buy 8
    30 Days Ago 1.429 Strong Buy 7
    60 Days Ago 1.429 Strong Buy 7
    90 Days Ago 1.429 Strong Buy 7
    120 Days Ago 1.429 Strong Buy 7

  • Analyst Ratings: OREX

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Rodman & Renshaw — Mkt Outperform 06/24/2009 14.00
    Lazard Capital Mkts — Buy 03/13/2009 10.00
    Leerink Swann — Outperform 08/25/2008 —
    Cowen & Co — Outperform 04/03/2008 —
    Lazard Capital — Buy 02/06/2008 —
    Canaccord Adams — Buy 02/04/2008 32.00
    JP Morgan — Overweight 01/03/2008 —
    JMP Securities Mkt Outperform Strong Buy 10/03/2007 26.00
    JP Morgan — Overweight 06/07/2007 —
    JMP Securities — Mkt Outperform 06/06/2007 26.00